Charles E. Inturrisi - Publications

Affiliations: 
Weill Cornell Medical College, New York, NY, United States 
Area:
Neuroscience Biology, Pharmacology, Molecular Biology

198 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Mehta N, Inturrisi CE, Horn SD, Witkin LR. Using Chronic Pain Outcomes Data to Improve Outcomes. Anesthesiology Clinics. 34: 395-408. PMID 27208717 DOI: 10.1016/j.anclin.2016.01.009  0.8
2015 Inturrisi CE, Gregusa AM. Mechanisms of opioid tolerance Cancer Pain: From Molecules to Suffering 0.8
2013 Xu J, Xu M, Brown T, Rossi GC, Hurd YL, Inturrisi CE, Pasternak GW, Pan YX. Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action. The Journal of Biological Chemistry. 288: 21211-27. PMID 23760268 DOI: 10.1074/jbc.M113.458687  0.8
2013 Bruehl S, Apkarian AV, Ballantyne JC, Berger A, Borsook D, Chen WG, Farrar JT, Haythornthwaite JA, Horn SD, Iadarola MJ, Inturrisi CE, Lao L, Mackey S, Mao J, Sawczuk A, et al. Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. The Journal of Pain : Official Journal of the American Pain Society. 14: 103-13. PMID 23374939 DOI: 10.1016/j.jpain.2012.10.016  0.8
2011 Schierberl K, Hao J, Tropea TF, Ra S, Giordano TP, Xu Q, Garraway SM, Hofmann F, Moosmang S, Striessnig J, Inturrisi CE, Rajadhyaksha AM. Cav1.2 L-type Ca²⁺ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 13562-75. PMID 21940447 DOI: 10.1523/JNEUROSCI.2315-11.2011  0.8
2011 Reid MC, Bennett DA, Chen WG, Eldadah BA, Farrar JT, Ferrell B, Gallagher RM, Hanlon JT, Herr K, Horn SD, Inturrisi CE, Lemtouni S, Lin YW, Michaud K, Morrison RS, et al. Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them. Pain Medicine (Malden, Mass.). 12: 1336-57. PMID 21834914 DOI: 10.1111/j.1526-4637.2011.01211.x  0.8
2011 Foley KM, Fins JJ, Inturrisi CE. A true believer's flawed analysis. Archives of Internal Medicine. 171: 867-8; author reply . PMID 21555672 DOI: 10.1001/archinternmed.2011.166  0.8
2011 Hunter DA, Barr GA, Amador N, Shivers KY, Kemen L, Kreiter CM, Jenab S, Inturrisi CE, Quinones-Jenab V. Estradiol-induced antinociceptive responses on formalin-induced nociception are independent of COX and HPA activation. Synapse (New York, N.Y.). 65: 643-51. PMID 21132813 DOI: 10.1002/syn.20890  0.8
2010 Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, Fine PG, Foley KM, Gallagher RM, Gilson AM, Haddox JD, Horn SD, Inturrisi CE, Jick SS, Lipman AG, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. The Journal of Pain : Official Journal of the American Pain Society. 11: 807-29. PMID 20430701 DOI: 10.1016/j.jpain.2010.02.019  0.8
2010 Gregus AM, Inra CN, Giordano TP, Costa AC, Rajadhyaksha AM, Inturrisi CE. Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5. Neuroscience. 169: 475-87. PMID 20359526 DOI: 10.1016/j.neuroscience.2010.03.051  0.8
2010 Weyerbacher AR, Xu Q, Tamasdan C, Shin SJ, Inturrisi CE. N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory pain. Pain. 148: 237-46. PMID 20005044 DOI: 10.1016/j.pain.2009.11.003  0.8
2010 Gregus AM, Tropea TF, Wang Y, Hauck SC, Costa AC, Rajadhyaksha AM, Inturrisi CE. Deletion of the GluR5 subunit of kainate receptors affects cocaine sensitivity and preference. Neuroscience Letters. 468: 186-9. PMID 19878705 DOI: 10.1016/j.neulet.2009.10.071  0.8
2009 Klein G, Rossi GC, Waxman AR, Arout C, Juni A, Inturrisi CE, Kest B. The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence. Neuroscience Letters. 457: 115-9. PMID 19429175 DOI: 10.1016/j.neulet.2009.04.012  0.8
2009 Garraway SM, Xu Q, Inturrisi CE. siRNA-mediated knockdown of the NR1 subunit gene of the NMDA receptor attenuates formalin-induced pain behaviors in adult rats. The Journal of Pain : Official Journal of the American Pain Society. 10: 380-90. PMID 19185544 DOI: 10.1016/j.jpain.2008.09.013  0.8
2009 Bogulavsky JJ, Gregus AM, Kim PT, Costa AC, Rajadhyaksha AM, Inturrisi CE. Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine tolerance. The Journal of Pharmacology and Experimental Therapeutics. 328: 579-87. PMID 18957577 DOI: 10.1124/jpet.108.144121  0.8
2009 Inturrisi CE. Pharmacogenetic considerations in the treatment of cancer pain Cancer Pain: Assessment and Management, Second Edition. 180-194. DOI: 10.1017/CBO9780511642357.011  0.8
2009 Inturrisi CE. Pharmacology of analgesia: Basic principles Cancer Pain: Assessment and Management, Second Edition. 167-179. DOI: 10.1017/CBO9780511642357.010  0.8
2008 Xu Q, Garraway SM, Weyerbacher AR, Shin SJ, Inturrisi CE. Activation of the neuronal extracellular signal-regulated kinase 2 in the spinal cord dorsal horn is required for complete Freund's adjuvant-induced pain hypersensitivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 14087-96. PMID 19109491 DOI: 10.1523/JNEUROSCI.2406-08.2008  0.8
2008 Cheng HT, Suzuki M, Hegarty DM, Xu Q, Weyerbacher AR, South SM, Ohata M, Inturrisi CE. Inflammatory pain-induced signaling events following a conditional deletion of the N-methyl-D-aspartate receptor in spinal cord dorsal horn. Neuroscience. 155: 948-58. PMID 18621103 DOI: 10.1016/j.neuroscience.2008.06.024  0.8
2008 Glass MJ, Hegarty DM, Oselkin M, Quimson L, South SM, Xu Q, Pickel VM, Inturrisi CE. Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice. Experimental Neurology. 213: 57-70. PMID 18614169 DOI: 10.1016/j.expneurol.2008.04.045  0.8
2008 Klein G, Juni A, Waxman AR, Arout CA, Inturrisi CE, Kest B. A survey of acute and chronic heroin dependence in ten inbred mouse strains: evidence of genetic correlation with morphine dependence. Pharmacology, Biochemistry, and Behavior. 90: 447-52. PMID 18472145 DOI: 10.1016/j.pbb.2008.03.030  0.8
2008 Klein G, Juni A, Arout CA, Waxman AR, Inturrisi CE, Kest B. Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors. European Journal of Pharmacology. 586: 179-88. PMID 18343363 DOI: 10.1016/j.ejphar.2008.02.035  0.8
2008 Gordon D, Inturrisi CE, Greensmith JE, Brennan TJ, Goble L, Kerns RD. Perioperative pain management in the opioid-tolerant individual. The Journal of Pain : Official Journal of the American Pain Society. 9: 383-7. PMID 18337186 DOI: 10.1016/j.jpain.2008.01.331  0.8
2008 Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi CE, James AH, Laraque D, Mendez MH, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M. NIH consensus development statement on hydroxyurea treatment for sickle cell disease. Nih Consensus and State-of-the-Science Statements. 25: 1-30. PMID 18309362  0.8
2007 Sekine R, Obbens EA, Coyle N, Inturrisi CE. The successful use of parenteral methadone in a patient with a prolonged QTc interval. Journal of Pain and Symptom Management. 34: 566-9. PMID 17616330 DOI: 10.1016/j.jpainsymman.2007.05.001  0.8
2007 Garraway SM, Xu Q, Inturrisi CE. Design and evaluation of small interfering RNAs that target expression of the N-methyl-D-aspartate receptor NR1 subunit gene in the spinal cord dorsal horn. The Journal of Pharmacology and Experimental Therapeutics. 322: 982-8. PMID 17551091 DOI: 10.1124/jpet.107.123125  0.8
2007 Mannino CA, South SM, Quinones-Jenab V, Inturrisi CE. Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin test. The Journal of Pain : Official Journal of the American Pain Society. 8: 334-42. PMID 17140856 DOI: 10.1016/j.jpain.2006.10.002  0.8
2006 Pasternak GW, Inturrisi CE. Feeling pain? Who's your daddy.... Nature Medicine. 12: 1243-4. PMID 17088889 DOI: 10.1038/nm1106-1243  0.8
2006 Kuba T, Wu HB, Nazarian A, Festa ED, Barr GA, Jenab S, Inturrisi CE, Quinones-Jenab V. Estradiol and progesterone differentially regulate formalin-induced nociception in ovariectomized female rats. Hormones and Behavior. 49: 441-9. PMID 16257405 DOI: 10.1016/j.yhbeh.2005.09.007  0.8
2006 Inturrisi CE. Characterization of Pain Receptors in the Spinal Cord Using a Viral Vector for Spatial-Temporal Gene Targeting Gene Therapy of the Central Nervous System: From Bench to Bedside. 223-229. DOI: 10.1016/B978-012397632-1/50018-6  0.8
2005 Mannino CA, South SM, Inturrisi CE, Quinones-Jenab V. Pharmacokinetics and effects of 17beta-estradiol and progesterone implants in ovariectomized rats. The Journal of Pain : Official Journal of the American Pain Society. 6: 809-16. PMID 16326369 DOI: 10.1016/j.jpain.2005.07.007  0.8
2005 Inturrisi CE. Pharmacology of methadone and its isomers Minerva Anestesiologica. 71: 435-437. PMID 16012416  0.8
2005 Inturrisi CE. The role of N-methyl-D-aspartate (NMDA) receptors in pain and morphine tolerance Minerva Anestesiologica. 71: 401-403. PMID 16012411  0.8
2005 Shimoyama N, Shimoyama M, Davis AM, Monaghan DT, Inturrisi CE. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance. The Journal of Pharmacology and Experimental Therapeutics. 312: 834-40. PMID 15388787 DOI: 10.1124/jpet.104.074856  0.8
2003 Jenab S, Festa ED, Russo SJ, Wu HB, Inturrisi CE, Quinones-Jenab V. MK-801 attenuates cocaine induction of c-fos and preprodynorphin mRNA levels in Fischer rats. Brain Research. Molecular Brain Research. 117: 237-9. PMID 14559159 DOI: 10.1016/S0169-328X(03)00319-X  0.8
2003 Manfredi PL, Foley KM, Payne R, Houde R, Inturrisi CE. Parenteral methadone: an essential medication for the treatment of pain. Journal of Pain and Symptom Management. 26: 687-8. PMID 12906950 DOI: 10.1016/S0885-3924(03)00259-8  0.8
2003 Walker JR, Chen SA, Moffitt H, Inturrisi CE, Koob GF. Chronic opioid exposure produces increased heroin self-administration in rats. Pharmacology, Biochemistry, and Behavior. 75: 349-54. PMID 12873626 DOI: 10.1016/S0091-3057(03)00094-7  0.8
2003 South SM, Kohno T, Kaspar BK, Hegarty D, Vissel B, Drake CT, Ohata M, Jenab S, Sailer AW, Malkmus S, Masuyama T, Horner P, Bogulavsky J, Gage FH, Yaksh TL, ... ... Inturrisi CE, et al. A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 5031-40. PMID 12832526  0.8
2003 Zhu H, Brodsky M, Gorman AL, Inturrisi CE. Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614. Brain Research. Molecular Brain Research. 114: 154-62. PMID 12829326 DOI: 10.1016/S0169-328X(03)00170-0  0.8
2003 Zhu H, Jenab S, Jones KL, Inturrisi CE. The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat. Brain Research. Developmental Brain Research. 142: 209-13. PMID 12711372 DOI: 10.1016/S0165-3806(03)00059-2  0.8
2002 Inturrisi CE. Clinical pharmacology of opioids for pain. The Clinical Journal of Pain. 18: S3-13. PMID 12479250 DOI: 10.1097/00002508-200207001-00002  0.8
2002 Jenab S, Inturrisi CE. Retinoic acid regulation of mu opioid receptor and c-fos mRNAs and AP-1 DNA binding in SH-SY5Y neuroblastoma cells. Brain Research. Molecular Brain Research. 99: 34-9. PMID 11869806 DOI: 10.1016/S0169-328X(01)00343-6  0.8
2002 Jones KL, Zhu H, Jenab S, Du T, Inturrisi CE, Barr GA. Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 301-10. PMID 11850145 DOI: 10.1016/S0893-133X(01)00347-5  0.8
2001 Davis AM, Inturrisi CE. Attenuation of hyperalgesia by LY235959, a competitive N-methyl-D-aspartate receptor antagonist Brain Research. 894: 150-153. PMID 11245826 DOI: 10.1016/S0006-8993(00)03325-4  0.8
1999 Shimoyama M, Shimoyama N, Gorman AL, Elliott KJ, Inturrisi CE. Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine. Pain. 81: 85-93. PMID 10353496 DOI: 10.1016/S0304-3959(98)00269-3  0.8
1999 Davis AM, Inturrisi CE. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia Journal of Pharmacology and Experimental Therapeutics. 289: 1048-1053. PMID 10215686  0.8
1999 Collins JJ, Dunkel IJ, Gupta SK, Inturrisi CE, Lapin J, Palmer LN, Weinstein SM, Portenoy RK. Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. The Journal of Pediatrics. 134: 319-23. PMID 10064669  0.8
1999 Kest B, Jenab S, Brodsky M, Sadowski B, Belknap JK, Mogil JS, Inturrisi CE. Mu and delta opioid receptor analgesia, binding density, and mRNA levels in mice selectively bred for high and low analgesia. Brain Research. 816: 381-9. PMID 9878841 DOI: 10.1016/S0006-8993(98)01141-X  0.8
1999 Portenoy RK, Caraceni A, Cherny NI, Goldblum R, Ingham J, Inturrisi CE, Johnson JH, Lapin J, Tiseo PJ, Kreek MJ. Dynorphin A(1-13) analgesia in opioid-treated patients with chronic pain. A controlled pilot study Clinical Drug Investigation. 17: 33-42. DOI: 10.2165/00044011-199917010-00004  0.8
1999 Inturrisi CE. Old dogs, new tricks Pain Forum. 8: 210-212.  0.8
1998 Kest B, McLemore GL, Sadowski B, Mogil JS, Belknap JK, Inturrisi CE. Acute morphine dependence in mice selectively-bred for high and low analgesia. Neuroscience Letters. 256: 120-2. PMID 9853718 DOI: 10.1016/S0304-3940(98)00772-1  0.8
1998 Kest B, Beczkowska I, Franklin SO, Lee CE, Mogil JS, Inturrisi CE. Differences in delta opioid receptor antinociception, binding, and mRNA levels between BALB/c and CXBK mice. Brain Research. 805: 131-7. PMID 9733948 DOI: 10.1016/S0006-8993(98)00696-9  0.8
1998 Kest B, Lee CE, Jenab S, Kao B, Inturrisi CE. Chronic naltrexone differentially affects supraspinal δ-opioid receptor-mediated antinociception European Journal of Pharmacology. 345: 47-53. PMID 9593593 DOI: 10.1016/S0014-2999(97)01584-7  0.8
1997 McLemore GL, Kest B, Inturrisi CE. The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence Brain Research. 778: 120-126. PMID 9462883 DOI: 10.1016/S0006-8993(97)00985-2  0.8
1997 Kest B, McLemore G, Kao B, Inturrisi CE. The competitive α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to Delta or Kappa opioids Journal of Pharmacology and Experimental Therapeutics. 283: 1249-1255. PMID 9400000  0.8
1997 Lee CE, Kest B, Jenab S, Inturrisi CE. Effect of supraspinal antisense oligodeoxynucleotide treatment on δ-opioid receptor mRNA levels in mice Molecular Brain Research. 48: 17-22. PMID 9379841 DOI: 10.1016/S0169-328X(97)00054-5  0.8
1997 Shimoyama N, Shimoyama M, Elliott KJ, Inturrisi CE. d-Methadone is antinociceptive in the rat formalin test. The Journal of Pharmacology and Experimental Therapeutics. 283: 648-52. PMID 9353381  0.8
1997 Shimoyama M, Shimoyama N, Inturrisi CE, Elliott KJ. Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain. 72: 375-82. PMID 9313278 DOI: 10.1016/S0304-3959(97)00065-1  0.8
1997 Jenab S, Inturrisi CE. Activation of protein kinase A prevents the ethanol-induced up-regulation of δ-opioid receptor mRNA in NG108-15 cells Molecular Brain Research. 47: 44-48. PMID 9221900 DOI: 10.1016/S0169-328X(97)00061-2  0.8
1997 Beczkowska IW, Gracy KN, Pickel VM, Inturrisi CE. Inducible expression of N-methyl-D-aspartate receptor, and delta and mu opioid receptor messenger RNAs and protein in the NT2-N human cell line. Neuroscience. 79: 855-62. PMID 9219948 DOI: 10.1016/S0306-4522(97)00034-1  0.8
1997 Shimoyama N, Shimoyama M, Davis AM, Inturrisi CE, Elliott KJ. Spinal gabapentin is antinociceptive in the rat formalin test. Neuroscience Letters. 222: 65-7. PMID 9121725 DOI: 10.1016/S0304-3940(97)13331-6  0.8
1997 Gorman AL, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neuroscience Letters. 223: 5-8. PMID 9058409 DOI: 10.1016/S0304-3940(97)13391-2  0.8
1997 Kest B, Lee CE, Mogil JS, Inturrisi CE. Blockade of morphine supersensitivity by an antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1). Life Sciences. 60: PL155-9. PMID 9048971 DOI: 10.1016/S0024-3205(96)00704-7  0.8
1997 Shimoyama M, Shimoyama N, Inturrisi CE, Elliott K. Oral ketamine produces a dose-dependent CNS depression in the rat. Life Sciences. 60: PL9-14. PMID 8995536  0.8
1997 Beczkowska IW, Gracy KN, Pickel VM, Inturrisi CE. Detection of delta opioid receptor and N-methyl-D-aspartate receptor-like immunoreactivity in retinoic acid-differentiated neuroblastoma x glioma (NG108-15) cells. Journal of Neuroscience Research. 47: 83-9. PMID 8981241 DOI: 10.1002/(SICI)1097-4547(19970101)47:1<83::AID-JNR9>3.0.CO;2-B  0.8
1997 Inturrisi CE. Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence Seminars in the Neurosciences. 9: 110-119. DOI: 10.1006/smns.1997.0111  0.8
1996 Bilsky EJ, Inturrisi CE, Sadée W, Hruby VJ, Porreca F. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or δ opioid agonists in mice Pain. 68: 229-237. PMID 9121809 DOI: 10.1016/S0304-3959(96)03185-5  0.8
1996 Shimoyama N, Shimoyama M, Inturrisi CE, Elliott KJ. Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology. 85: 1357-66. PMID 8968183 DOI: 10.1097/00000542-199612000-00017  0.8
1996 Payne R, Gradert TL, Inturrisi CE. Cerebrospinal fluid distribution of opioids after intraventricular and lumbar subarachnoid administration in sheep Life Sciences. 59: 1307-1321. PMID 8876660 DOI: 10.1016/0024-3205(96)00456-0  0.8
1996 Beczkowska IW, Buck J, Inturrisi CE. Retinoic acid-induced increase in delta-opioid receptor and N-methyl-D-aspartate receptor mRNA levels in neuroblastoma X glioma (NG108-15) cells Brain Research Bulletin. 39: 193-199. PMID 8866697 DOI: 10.1016/0361-9230(95)02104-3  0.8
1996 Kest B, Lee CE, McLemore GL, Inturrisi CE. An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice Brain Research Bulletin. 39: 185-188. PMID 8866695 DOI: 10.1016/0361-9230(95)02092-6  0.8
1995 Chan K, Brodsky M, Davis T, Franklin S, Inturrisi CE, Yoburn BC. The effect of the irreversible μ-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNA European Journal of Pharmacology. 287: 135-143. PMID 8749027 DOI: 10.1016/0014-2999(95)00488-2  0.8
1995 Elliott K, Kest B, Man A, Kao B, Inturrisi CE. N-methyl-d-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development Neuropsychopharmacology. 13: 347-356. PMID 8747759 DOI: 10.1016/0893-133X(95)00083-P  0.8
1995 Jenab S, Kest B, Inturrisi CE. Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatment Brain Research. 691: 69-75. PMID 8590066 DOI: 10.1016/0006-8993(95)00615-W  0.8
1995 Elliott KJ, Brodsky M, Hynansky A, Foley KM, Inturrisi CE. Dextromethorphan shows efficacy in experimental pain (nociception) and opioid tolerance Neurology. 45: S66-S68. PMID 8545027  0.8
1995 Jenab S, Kest B, Franklin SO, Inturrisi CE. Quantitative distribution of the delta opioid receptor mrna in the mouse and rat CNS Life Sciences. 56: 2343-2355. PMID 7791521 DOI: 10.1016/0024-3205(95)00228-X  0.8
1995 Jenab S, Inturrisi CE. Proenkephalin gene expression: Interaction of glucocorticoid and cAMP regulatory elements Biochemical and Biophysical Research Communications. 210: 589-599. PMID 7755638 DOI: 10.1006/bbrc.1995.1700  0.8
1995 Cheng PY, Svingos AL, Wang H, Clarke CL, Jenab S, Beczkowska IW, Inturrisi CE, Pickel VM. Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 5976-88. PMID 7666182  0.8
1995 Tiseo PJ, Thaler HT, Lapin J, Inturrisi CE, Portenoy RK, Foley KM. Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients Pain. 61: 47-54. PMID 7644248 DOI: 10.1016/0304-3959(94)00148-8  0.8
1995 Rasmussen K, Brodsky M, Inturrisi CE. NMDA antagonists and clonidine block c-fos expression during morphine withdrawal Synapse. 20: 68-74. PMID 7624831  0.8
1995 Brodsky M, Elliott K, Hynansky A, Jenab S, Inturrisi CE. Quantitation of μ-opioid receptor (MOR-1) mRNA in selected regions of the rat CNS Neuroreport. 6: 725-729. PMID 7605935  0.8
1995 Standifer KM, Jenab S, Su W, Chien CC, Pan YX, Inturrisi CE, Pasternak GW. Antisense oligodeoxynucleotides to the cloned δ receptor DOR-1: Uptake, stability, and regulation of gene expression Journal of Neurochemistry. 65: 1981-1987. PMID 7595481  0.8
1995 Brodsky M, Elliott K, Hynansky A, Inturrisi CE. CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone Brain Research Bulletin. 38: 135-141. PMID 7583338 DOI: 10.1016/0361-9230(95)00079-T  0.8
1995 Zhu Ys, Franklin SO, Inturrisi CE. Differential regulation of c-fos, proenkephalin and tyrosine hydroxylase gene expression by metrazole in the hamster adrenal and hippocampus Neuroscience Letters. 196: 197-200. PMID 7501282 DOI: 10.1016/0304-3940(95)11877-Y  0.8
1995 Elliott KJ, Brodsky M, Hynansky AD, Foley KM, Inturrisi CE. Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA Pain. 61: 401-409. PMID 7478683 DOI: 10.1016/0304-3959(94)00214-Y  0.8
1995 Pasternak GW, Inturrisi CE. Section review central & peripheral nervous systems: Pharmacological modulation of opioid tolerance Expert Opinion On Investigational Drugs. 4: 271-281. DOI: 10.1517/13543784.4.4.271  0.8
1994 Tiseo PJ, Cheng J, Pasternak GW, Inturrisi CE. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: Assessment of opioid receptor changes Journal of Pharmacology and Experimental Therapeutics. 268: 195-201. PMID 8301558  0.8
1994 Zhu Yuan Shan, Branch AD, Robertson HD, Inturrisi CE. Cloning and characterization of hamster proenkephalin gene Dna and Cell Biology. 13: 25-35. PMID 8286036  0.8
1994 Burke RE, Franklin SO, Inturrisi CE. Acute and persistent suppression of preproenkephalin mRNA expression in the striatum following developmental hypoxic-ischemic injury. Journal of Neurochemistry. 62: 1878-86. PMID 8158136  0.8
1994 Gold LH, Stinus L, Inturrisi CE, Koob GF. Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. European Journal of Pharmacology. 253: 45-51. PMID 8013548 DOI: 10.1016/0014-2999(94)90755-2  0.8
1994 Kest B, Jenab S, Brodsky M, Elliott K, Inturrisi CE. Supraspinal delta opioid receptor mRNA levels are not altered in [D- Ala2]deltorphin II tolerant mice Journal of Neuroscience Research. 39: 674-679. PMID 7897702 DOI: 10.1002/jnr.490390608  0.8
1994 Jenab S, Inturrisi CE. Ethanol and naloxone differentially upregulate delta opioid receptor gene expression in neuroblastoma hybrid (NG108-15) cells Molecular Brain Research. 27: 95-102. PMID 7877460 DOI: 10.1016/0169-328X(94)90189-9  0.8
1994 Elliott RC, Inturrisi CE, Black IB, Dreyfus CF. An improved method detects differential NGF and BDNF gene expression in response to depolarization in cultured hippocampal neurons. Brain Research. Molecular Brain Research. 26: 81-8. PMID 7854070 DOI: 10.1016/0169-328X(94)90077-9  0.8
1994 Elliott K, Hynansky A, Inturrisi CE. Dextromethorphan attenuates and reverses analgesic tolerance to morphine Pain. 59: 361-368. PMID 7708410 DOI: 10.1016/0304-3959(94)90022-1  0.8
1994 Elliott K, Minami N, Kolesnikov YA, Pasternak GW, Inturrisi CE. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids Pain. 56: 69-75. PMID 7512709 DOI: 10.1016/0304-3959(94)90151-1  0.8
1994 Kest B, Jenab S, Inturrisi CE. [d-Ala2]Deltorphin II induced tolerance does not alter delta opioid receptor (DOR) mRNA levels in mouse CNS Regulatory Peptides. 54: 147-148. DOI: 10.1016/0167-0115(94)90433-2  0.8
1994 Inturrisi CE. NMDA receptors, nitric oxide and opioid tolerance Regulatory Peptides. 54: 129-130. DOI: 10.1016/0167-0115(94)90423-5  0.8
1994 Brodsky M, Elliott K, Hynansky A, Inturrisi CE. Strain differences in the analgesic potency of morphine and in mu opioid receptor mRNA levels in adult male mice Regulatory Peptides. 54: 33-34. DOI: 10.1016/0167-0115(94)90375-1  0.8
1993 Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, Yoo H, Inturrisi CE, Reis DJ. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature. 363: 260-3. PMID 8487863 DOI: 10.1038/363260a0  0.8
1993 Tiseo PJ, Inturrisi CE. Attenuation and reversal of morphine tolerance by the competitive N- methyl-D-aspartate receptor antagonist, LY274614 Journal of Pharmacology and Experimental Therapeutics. 264: 1090-1096. PMID 8450453  0.8
1993 Portenoy RK, Southam MA, Gupta SK, Lapin J, Layman M, Inturrisi CE, Foley KM. Transdermal fentanyl for cancer pain: Repeated dose pharmacokinetics Anesthesiology. 78: 36-43. PMID 8424569  0.8
1993 Zhu Ys, Inturrisi CE. Metrazole induction of c-fos and proenkephalin gene expression in the rat adrenal and hippocampus: pharmacological characterization Molecular Brain Research. 20: 118-124. PMID 8255173 DOI: 10.1016/0169-328X(93)90116-7  0.8
1993 Zhu YS, Brodsky M, Franklin SO, Huang T, Inturrisi CE. Metrazole induces the sequential activation of c-fos, proenkephalin, and tyrosine hydroxylase gene expression in the rat adrenal gland: Modulation by glucocorticoid and adrenocorticotropic hormone Molecular Pharmacology. 44: 328-335. PMID 8102782  0.8
1993 Zhu YS, Jones SB, Burke RE, Franklin SO, Inturrisi CE. Quantitation of the levels of tyrosine hydroxylase and preproenkephalin mRNAs in nigrostriatal sites after 6-hydroxydopamine lesions. Life Sciences. 52: 1577-84. PMID 8097862 DOI: 10.1016/0024-3205(93)90058-B  0.8
1993 Franklin SO, Elliott K, Zhu YS, Wahlestedt C, Inturrisi CE. Quantitation of NMDA receptor (NMDAR1) mRNA levels in the adult and developing rat CNS. Brain Research. Molecular Brain Research. 19: 93-100. PMID 7689684 DOI: 10.1016/0169-328X(93)90153-G  0.8
1993 Zhu YS, Jones SB, Franklin SO, Inturrisi CE. Induction of tyrosine hydroxylase mRNA by protein synthesis inhibitors in the rat adrenal Molecular and Cellular Neuroscience. 4: 285-291.  0.8
1992 Culpepper‐Morgan JA, Inturrisi CE, Portenoy RK, Foley K, Houde RW, Marsh F, Kreek MJ. Treatment of opioid‐induced constipation with oral naloxone: A pilot study Clinical Pharmacology &Amp; Therapeutics. 52: 90-95. PMID 1623695 DOI: 10.1038/clpt.1992.106  0.8
1992 Portenoy RK, Thaler HT, Inturrisi CE, Friedlander-Klar H, Foley KM. The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function Clinical Pharmacology and Therapeutics. 51: 422-431. PMID 1563212 DOI: 10.1038/clpt.1992.42  0.8
1992 Zhu YS, Branch AD, Robertson HD, Huang TH, Franklin SO, Inturrisi CE. Time course of enkephalin mRNA and peptides in cultured rat adrenal medulla Molecular Brain Research. 12: 173-180. PMID 1372065 DOI: 10.1016/0169-328X(92)90081-L  0.8
1992 Candido J, Lutfy K, Billings B, Sierra V, Duttaroy A, Inturrisi CE, Yoburn BC. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation Pharmacology, Biochemistry and Behavior. 42: 685-692. PMID 1325057 DOI: 10.1016/0091-3057(92)90015-8  0.8
1991 Hagen NA, Foley KM, Cerbone DJ, Portenoy RK, Inturrisi CE. Chronic nausea and morphine-6-glucuronide Journal of Pain and Symptom Management. 6: 125-128. PMID 2016556 DOI: 10.1016/0885-3924(91)90961-3  0.8
1991 Portenoy RK, Khan E, Layman M, Lapin J, Malkin MG, Foley KM, Thaler HT, Cerbone DJ, Inturrisi CE. Chronic morphine therapy for cancer pain: Plasma and cerebrospinal fluid morphine and morphine–6–glucuronide concentrations Neurology. 41: 1457-1461. PMID 1891098  0.8
1991 Portenoy RK, Foley KM, Stulman J, Khan E, Adelhardt J, Layman M, Cerbone DF, Inturrisi CE. Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure Pain. 47: 13-19. PMID 1771088 DOI: 10.1016/0304-3959(91)90005-I  0.8
1991 Franklin SO, Zhu YS, Yoburn BC, Inturrisi CE. Transsynaptic activity regulates proenkephalin and tyrosine hydroxylase gene expression and the response to reserpine in the hamster adrenal Molecular Pharmacology. 40: 515-522. PMID 1717819  0.8
1991 Franklin SO, Yoburn BC, Zhu YS, Branch AD, Robertson HD, Inturrisi CE. Preproenkephalin mRNA and enkephalin in normal and denervated adrenals in the Syrian hamster: comparison with central nervous system tissues Molecular Brain Research. 10: 241-250. PMID 1653391 DOI: 10.1016/0169-328X(91)90067-8  0.8
1991 Portenoy RK, Foley KM, Inturrisi CE. Response to the letters to the editor by Dr. Du Pen and Ms. A. Williams and by Drs. Arnér and Meyerson Pain. 47: 119-121. DOI: 10.1016/0304-3959(91)90020-X  0.8
1990 Inturrisi CE, Portenoy RK, Max MB, Colburn WA, Foley KM. Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clinical Pharmacology and Therapeutics. 47: 565-77. PMID 2188771 DOI: 10.1038/clpt.1990.77  0.8
1990 Eisenach JC, Dobson CE, Inturrisi CE, Hood DD, Agner PB. Effect of pregnancy and pain on cerebrospinal fluid immunoreactive enkephalins and norepinephrine in healthy humans Pain. 43: 149-154. PMID 2087327 DOI: 10.1016/0304-3959(90)91067-S  0.8
1990 Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions Pain. 43: 273-286. PMID 1705692 DOI: 10.1016/0304-3959(90)90025-9  0.8
1989 Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. The Journal of Pharmacology and Experimental Therapeutics. 251: 477-83. PMID 2810109  0.8
1989 Inturrisi CE. Management of cancer pain. Pharmacology and principles of management Cancer. 63: 2308-2320. PMID 2566371  0.8
1989 Yoburn BC, Kreuscher SP, Inturrisi CE, Sierra V. Opioid receptor upregulation and supersensitivity in mice: Effect of morphine sensitivity Pharmacology, Biochemistry and Behavior. 32: 727-731. PMID 2544906 DOI: 10.1016/0091-3057(89)90025-7  0.8
1989 Inturrisi CE. Clinical pharmacology of opioid analgesics Anesthesiology Clinics of North America. 7: 33-49.  0.8
1988 Inturrisi CE, Branch AD, Robertson HD, Howells RD, Franklin SO, Shapiro JR, Calvano SE, Yoburn BC. Glucocorticoid regulation of enkephalins in cultured rat adrenal medulla Molecular Endocrinology. 2: 633-640. PMID 3412328 DOI: 10.1210/mend-2-7-633  0.8
1988 Inturrisi CE, LaGamma EF, Franklin SO, Huang T, Nip TJ, Yoburn BC. Characterization of enkephalins in rat adrenal medullary explants Brain Research. 448: 230-236. PMID 3378148 DOI: 10.1016/0006-8993(88)91260-7  0.8
1988 Yoburn BC, Inturrisi CE. Modification of the response to opioid and monopioid drugs by chronic opioid antagonist treatment Life Sciences. 42: 1689-1696. PMID 3362035 DOI: 10.1016/0024-3205(88)90034-3  0.8
1988 Bryant HU, Yoburn BC, Inturrisi CE, Bernton EW, Holaday JW. Morphine-induced immunomodulation is not related to serum morphine concentrations European Journal of Pharmacology. 149: 165-169. PMID 3260867 DOI: 10.1016/0014-2999(88)90057-X  0.8
1988 Yoburn BC, Luke MC, Pasternak GW, Inturrisi CE. Upregulation of opioid receptor subtypes correlates with potency changes of morphine and dadle Life Sciences. 43: 1319-1324. PMID 2845219 DOI: 10.1016/0024-3205(88)90587-5  0.8
1988 Weinberg DS, Inturrisi CE, Reidenberg B, Moulin DE, Tip TJ, Wallenstein S, Houde RW, Foley KM. Sublingual absorption of selected opioid analgesics Clinical Pharmacology and Therapeutics. 44: 335-342. PMID 2458208  0.8
1987 Inturrisi CE, Colburn WA, Kaiko RF, Houde RW, Foley KM. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain Clinical Pharmacology and Therapeutics. 41: 392-401. PMID 3829576  0.8
1987 Groeger JS, Inturrisi CE. High-dose naloxone: Pharmacokinetics in patients in septic shock Critical Care Medicine. 15: 751-756. PMID 3608532  0.8
1987 Wissel PS, Denke M, Inturrisi CE. A comparison of the effects of a macrobiotic diet and a western diet on drug metabolism and plasma lipids in man European Journal of Clinical Pharmacology. 33: 403-407. PMID 3443147 DOI: 10.1007/BF00637638  0.8
1987 Yoburn BC, Franklin SO, Calvano SE, Inturrisi CE. Regulation of rat adrenal medullary enkephalins by glucocorticoids Life Sciences. 40: 2495-2503. PMID 3037215 DOI: 10.1016/0024-3205(87)90070-1  0.8
1987 Foley KM, Inturrisi CE. Analgesic drug therapy in cancer pain: Principles and practice Medical Clinics of North America. 71: 207-232. PMID 2881032  0.8
1987 Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE. Morphine-6-glucuronide, a potent mu agonist. Life Sciences. 41: 2845-9. PMID 2826951 DOI: 10.1016/0024-3205(87)90431-0  0.8
1987 Yoburn BC, Truesdell LS, Kest B, Inturrisi CE, Bodnar RJ. Chronic opioid antagonist treatment facilitates nonopioid, stress-induced analgesia. Pharmacology, Biochemistry, and Behavior. 27: 525-7. PMID 2821554 DOI: 10.1016/0091-3057(87)90359-5  0.8
1986 Yoburn BC, Cohen AH, Inturrisi CE. Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat. The Journal of Pharmacology and Experimental Therapeutics. 237: 126-30. PMID 3958962  0.8
1986 Rawal N, Schott U, Dahlstrom B, Inturrisi CE, Tandon B, Sjöstrand U, Wennhager M. Influence of naloxone infusion on analgesia and respiratory depression following epidural morphine Anesthesiology. 64: 194-201. PMID 3946806  0.8
1986 Payne R, Madsen J, Harvey RC, Inturrisi CE. A chronic sheep preparation for the study of drug pharmacokinetics in spinal and ventricular CSF Journal of Pharmacological Methods. 16: 277-296. PMID 3784573 DOI: 10.1016/0160-5402(86)90032-X  0.8
1986 Moulin DE, Inturrisi CE, Foley KM. Cerebrospinal fluid pharmacokinetics of intrathecal morphine sulfate and D-Ala2-D-Leu5-enkephalin Annals of Neurology. 20: 218-222. PMID 3530119 DOI: 10.1002/ana.410200207  0.8
1986 Yoburn BC, Nunes FA, Adler B, Pasternak GW, Inturrisi CE. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse Journal of Pharmacology and Experimental Therapeutics. 239: 132-135. PMID 3020228  0.8
1985 Colburn WA, Inturrisi CE, Gram LF. D-propoxyphene: Accumulation or altered kinetics? European Journal of Clinical Pharmacology. 28: 725-726. PMID 4065198 DOI: 10.1007/BF00607926  0.8
1985 Yoburn BC, Chen J, Huang T, Inturrisi CE. Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat Journal of Pharmacology and Experimental Therapeutics. 235: 282-286. PMID 4057070  0.8
1985 Yoburn BC, Cohen A, Umans JG, Ling GSF, Inturrisi CE. The graded and quantal nature of opioid analgesia in the rat tailflick assay Brain Research. 331: 327-336. PMID 3986573 DOI: 10.1016/0006-8993(85)91558-6  0.8
1985 Moulin DE, Max MB, Kaiko RF, Inturrisi CE, Maggard J, Yaksh TL, Foley KM. The analgesic efficacy of intrathecal D-Ala2-D-Leu5-enkephalin in cancer patients with chronic pain. Pain. 23: 213-21. PMID 3906516 DOI: 10.1016/0304-3959(85)90099-5  0.8
1985 Yoburn BC, Goodman RR, Cohen AH, Pasternak GW, Inturrisi CE. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment. Life Sciences. 36: 2325-32. PMID 2989632 DOI: 10.1016/0024-3205(85)90322-4  0.8
1985 Max MB, Inturrisi CE, Kaiko RF, Grabinski PY, Li CH, Foley KM. Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain. Clinical Pharmacology and Therapeutics. 38: 631-41. PMID 2415286  0.8
1984 Yoburn BC, Morales R, Kelly DD, Inturrisi CE. Constraints on the tailflick assay: Morphine analgesia and tolerance are dependent upon locus of tail stimulation Life Sciences. 34: 1755-1762. PMID 6727545 DOI: 10.1016/0024-3205(84)90575-7  0.8
1984 Inturrisi CE, Max MB, Foley KM, Schultz M, Shin SU, Houde RW. The pharmacokinetics of heroin in patients with chronic pain. The New England Journal of Medicine. 310: 1213-7. PMID 6709027 DOI: 10.1056/NEJM198405103101902  0.8
1984 Ling GSF, Tappe NS, Inturrisi CE. Methadone induced physical dependence in the rat Life Sciences. 34: 683-690. PMID 6538254 DOI: 10.1016/0024-3205(84)90233-9  0.8
1984 Yoburn BC, Morales R, Inturrisi CE. Chronic vascular catheterization in the rat: Comparison of three techniques Physiology and Behavior. 33: 89-94. PMID 6505057 DOI: 10.1016/0031-9384(84)90018-0  0.8
1984 Inturrisi CE. Role of opioid analgesics American Journal of Medicine. 77: 27-37. PMID 6486129  0.8
1983 Grevert P, Albert LH, Inturrisi CE, Goldstein A. Effects of eight-hour naloxone infusions on human subjects Biological Psychiatry. 18: 1375-1392. PMID 6661468  0.8
1983 Judson BA, Goldstein A, Inturrisi CE. Methadyl Acetate (LAAM) in the Treatment of Heroin Addicts: II. Double-blind Comparison of Gradual and Abrupt Detoxification Archives of General Psychiatry. 40: 834-840. PMID 6347117 DOI: 10.1001/archpsyc.1983.01790070024003  0.8
1983 Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L, Simon EJ. Evidence from opiate binding studies that heroin acts through its metabolites Life Sciences. 33: 773-776. PMID 6319928 DOI: 10.1016/0024-3205(83)90616-1  0.8
1983 Margules DL, Inturrisi CE. Beta-endorphin immunoreactivity in the plasma of patients with the Prader-Labhart-Willi syndrome and their normal siblings. Experientia. 39: 766-7. PMID 6305703 DOI: 10.1007/BF01990316  0.8
1983 Alexopoulos GS, Inturrisi CE, Lipman R, Frances R, Haycox J, Dougherty JH, Rossier J. Plasma immunoreactive beta-endorphin levels in depression. Effect of electroconvulsive therapy. Archives of General Psychiatry. 40: 181-3. PMID 6297423 DOI: 10.1001/archpsyc.1983.01790020079007  0.8
1983 Kaiko RF, Foley KM, Grabinski PY, Heidrich G, Rogers AG, Inturrisi CE, Reidenberg MM. Central nervous system excitatory effects of meperidine in cancer patients Annals of Neurology. 13: 180-185. PMID 6187275 DOI: 10.1002/ana.410130213  0.8
1983 Hahn EF, Lahita R, Kreek MJ, Duma C, Inturrisi CE. Naloxone radioimmunoassay: an improved antiserum Journal of Pharmacy and Pharmacology. 35: 833-836. PMID 6141253 DOI: 10.1111/j.2042-7158.1983.tb02910.x  0.8
1983 Inturrisi CE, Umans JG. Pethidine and its active metabolite, norpethidine Clinics in Anaesthesiology. 1: 123-138.  0.8
1983 Perry S, Inturrisi CE. Analgesia and morphine disposition in burn patients Journal of Burn Care and Rehabilitation. 4: 276-279.  0.8
1982 Umans JG, Chiu TSK, Lipman RA, Schultz MF, Shin SU, Inturrisi CE. Determination of heroin and its metabolites by high-performance liquid chromatography Journal of Chromatography B: Biomedical Sciences and Applications. 233: 213-225. PMID 7161334 DOI: 10.1016/S0378-4347(00)81748-X  0.8
1982 Umans JG, Inturrisi CE. Heroin: Analgesia, toxicity and disposition in the mouse European Journal of Pharmacology. 85: 317-323. PMID 7151874 DOI: 10.1016/0014-2999(82)90218-7  0.8
1982 Umans JG, Inturrisi CE. Antinociceptive activity and toxicity of meperidine and normeperidine in mice Journal of Pharmacology and Experimental Therapeutics. 223: 203-206. PMID 7120119  0.8
1982 Inturrisi CE, Colburn WA, Verebey K, Dayton HE, Woody GE, O'Brien CP. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene Clinical Pharmacology and Therapeutics. 31: 157-167. PMID 7056023  0.8
1982 Inturrisi CE, Alexopoulos G, Lipman R, Foley K, Rossier J. β‐ENDORPHIN IMMUNOREACTIVITY IN THE PLASMA OF PSYCHIATRIC PATIENTS RECEIVING ELECTROCONVULSIVE TREATMENT Annals of the New York Academy of Sciences. 398: 413-423. PMID 6297361 DOI: 10.1111/j.1749-6632.1982.tb39512.x  0.8
1982 Inturrisi CE. Narcotic drugs Medical Clinics of North America. 66: 1061-1071. PMID 6127453  0.8
1982 Ling GSF, Tappe NS, Inturrisi CE. Physical dependence to methadone and morphine in the rat Federation Proceedings. 41.  0.8
1981 Szeto HH, Clapp JF, Larrow RW, Hewitt J, Inturrisi CE, Mann LI. Disposition of methadone in the ovine maternal-fetal unit Life Sciences. 28: 2111-2117. PMID 7253804 DOI: 10.1016/0024-3205(81)90617-2  0.8
1981 Umans JG, Inturrisi CE. Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice Journal of Pharmacology and Experimental Therapeutics. 218: 409-415. PMID 7252840  0.8
1981 Kiang CH, Campos-Flor S, Inturrisi CE. Determination of acetylmethadol and metabolites by use of high-performance liquid chromatography Journal of Chromatography B: Biomedical Sciences and Applications. 222: 81-93. PMID 7217329 DOI: 10.1016/S0378-4347(00)81035-X  0.8
1981 Ling GSF, Umans JG, Inturrisi CE. Methadone: Radioimmunoassay and pharmacokinetics in the rat Journal of Pharmacology and Experimental Therapeutics. 217: 147-151. PMID 7205649  0.8
1981 Max M, Inturrisi CE, Grabinski P. Epidural opiates: Plasma and cerebrospinal fluid (CSF) pharmacokinetics of morphine, methadone and beta-endorphin Pain. 10. DOI: 10.1016/0304-3959(81)90353-5  0.8
1981 Umans JG, Inturrisi CE. Analgesic activity of methadone, l,α-acetylmethadol and its normetabolites after intracerebroventricular administration to mice Research Communications in Substances of Abuse. 2: 291-302.  0.8
1981 Max MB, Inturrisi CE, Grabinski P. Epidural opiates: Plasma and cerebrospinal fluid (CSF) pharmacokinetics of morphine, methadone, and beta-endorphin Neurology. 31: 95.  0.8
1981 Inturrisi CE, Foley KM, Kaiko RF, Houde RW. Disposition and effects of intravenous (IV) methadone (MET) in cancer patients Pain. 10.  0.8
1980 Szeto HH, Clapp JF, Larrow RW, Inturrisi CE, Mann LI. Renal tubular secretion of meperidine by the fetal lamb Journal of Pharmacology and Experimental Therapeutics. 213: 346-349. PMID 7365693  0.8
1980 Inturrisi CE, Umans JG, Wolff D, Stern AS, Lewis RV, Stein S, Udenfriend S. Analgesic activity of the naturally occurring heptapeptide [Met]enkephalin-Arg6-Phe7. Proceedings of the National Academy of Sciences of the United States of America. 77: 5512-4. PMID 6933569  0.8
1980 Foley KM, Inturrisi CE. Intrathecal beta-endorphin Lancet. 2: 317. PMID 6105462  0.8
1980 Umans JG, Inturrisi CE. Pharmacodynamics of heroin and its metabolites in the mouse Federation Proceedings. 39: 3821.  0.8
1980 Ling GSF, Umans JG, Inturrisi CE. Methadone pharmacokinetics in the rat: S.C. and I.P. administration Federation Proceedings. 39: 3819.  0.8
1979 Yaksh TL, Wilson PR, Kaiko RF, Inturrisi CE. Analgesia produced by a spinal action of morphine and effects upon parturition in the rat Anesthesiology. 51: 386-392. PMID 582883  0.8
1979 Szeto HH, Kaiko RF, Clapp JF, Larrow RW, Mann LI, Inturrisi CE. Urinary excretion of meperidine by the fetal lamb Journal of Pharmacology and Experimental Therapeutics. 209: 244-248. PMID 439000  0.8
1979 Foley KM, Kourides IA, Inturrisi CE, Kaiko RF, Zaroulis CG, Posner JB, Houde RW, Li CH. β-Endorphin: Analgesic and hormonal effects in humans Proceedings of the National Academy of Sciences of the United States of America. 76: 5377-5381. PMID 291954 DOI: 10.1073/pnas.76.10.5377  0.8
1978 Szeto HH, Zervoudakis IA, Cederqvist LL, Inturrisi CE. Amniotic fluid transfer of meperidine from maternal plasma in early pregnancy Obstetrics and Gynecology. 52: 59-62. PMID 683632  0.8
1978 Szeto HH, Mann LI, Bhakthavathsalan A, Liu M, Inturrisi CE. Meperidine pharmacokinetics in the maternal-fetal unit Journal of Pharmacology and Experimental Therapeutics. 206: 448-459. PMID 682125  0.8
1978 Chatterjie N, Umans JG, Inturrisi CE, Chen WTC, Clarke DD, Bhatnagar SP, Weiss U. A correction on the reduction of dihydrocodeinone with formamidinesulfinic acid. Stereoselective reduction of dihydropseudocodeinone Journal of Organic Chemistry. 43: 1003-1005.  0.8
1978 Szeto H, Clapp J, Mann LI, Inturrisi CE. Methadone distribution and elimination by mother and fetus Federation Proceedings. 37.  0.8
1977 Szeto HH, Inturrisi CE, Houde R, Saal S, Cheigh J, Reidenberg MM. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer Annals of Internal Medicine. 86: 738-741. PMID 869353  0.8
1977 Inturrisi CE. Disposition of narcotics in patients with renal disease The American Journal of Medicine. 62: 528-529. PMID 851125  0.8
1977 Inturrisi CE, Viederman M, Rusk GH, Lowenthal DT, White RP, Friedman EA, Boris A, David DS, Shahidi NT, Stenzel KH. Combined seminar on the use of drugs in renal failure. Narcotics, psychotherapeutic agents, antiarrhythmics, antihypertensives, sorbents, vitamin D and its analogues, anabolic hormones and nutritional supplements The American Journal of Medicine. 62: 527. PMID 851124  0.8
1977 Flor SC, Inturrisi CE. Separation of radiolabeled acetyl methadol and metabolites by thin-layer chromatography Journal of Analytical Toxicology. 1: 75. DOI: 10.1093/jat/1.2.75  0.8
1977 Szeto HH, Inturrisi CE, Bhakthavathsalan A. A pharmacokinetic model describing the distribution and elimination of meperidine in the maternal fetal unit Gynecologic Investigation. 8.  0.8
1976 Kaiki RF, Chatterjie N, Inturrisi CE. Simultaneous determination of acetyl-methadol and its active biotransformation products in human biofluids. 1975 [proceedings] Nida Research Monograph. 79. PMID 995182  0.8
1976 Szeto HH, Inturrisi CE. Simultaneous determination of meperidine and normeperidine in biofluids Journal of Chromatography A. 125: 503-510. PMID 993288 DOI: 10.1016/S0021-9673(00)85713-1  0.8
1976 Chattergie N, Umans JG, Inturrisi CE. Reduction of 6-ketones of the morphine series with formamidinesulfinic acid. Stereoselectivity opposite to that of hydride reductions Journal of Organic Chemistry. 41: 3624-3625. PMID 978305  0.8
1976 Inturrisi CE. Disposition of narcotics and narcotic antagonists Annals of the New York Academy of Sciences. 273-287. PMID 828465  0.8
1976 Dayton HE, Inturrisi CE. The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat Drug Metabolism and Disposition. 4: 474-478. PMID 10147  0.8
Show low-probability matches.